2.0
Oct 11, 2014
Anonymous employee
Former employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
Friendly colleagues; most people of similar level were nice and helpful. Focus on novel pursuit of interesting science. Unclear what could have been.
Cons
Pfizer merger was a huge drain; too many good people were displaced. Too much in fighting and not enough focus on science that could deliver - not enough asking the right questions.